Cellectar Biosciences, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cellectar Biosciences, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Cellectar Biosciences, Inc. Return On Assets for the quarter ending September 30, 2024 was -165 %, a 43.8% increase year-over-year.
  • Cellectar Biosciences, Inc. annual Return On Assets for 2023 was -311 %, a 142% decline from 2022.
  • Cellectar Biosciences, Inc. annual Return On Assets for 2022 was -129 %, a 143% decline from 2021.
  • Cellectar Biosciences, Inc. annual Return On Assets for 2021 was -53 %, a 1.72% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -311 -182 -142% Jan 1, 2023 Dec 31, 2023
2022 -129 -75.7 -143% Jan 1, 2022 Dec 31, 2022
2021 -53 +0.93 +1.72% Jan 1, 2021 Dec 31, 2021
2020 -54 +40.6 +43% Jan 1, 2020 Dec 31, 2020
2019 -94.6 +8.93 +8.63% Jan 1, 2019 Dec 31, 2019
2018 -104 +3.6 +3.36% Jan 1, 2018 Dec 31, 2018
2017 -107 -47.7 -80.1% Jan 1, 2017 Dec 31, 2017
2016 -59.5 +6.04 +9.22% Jan 1, 2016 Dec 31, 2016
2015 -65.5 +9.27 +12.4% Jan 1, 2015 Dec 31, 2015
2014 -74.8 +25.8 +25.6% Jan 1, 2014 Dec 31, 2014
2013 -101 -17.5 -21% Jan 1, 2013 Dec 31, 2013
2012 -83.1 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.